Posted by Michael Wonder on 17 Mar 2021
PHARMAC’s drug switch
17 March 2021 - PHARMAC's generic drug swap for epilepsy treatment saved $30 million over five years. But for some patients, the consequences were fatal.
One thing everybody involved with the inquest into the deaths of six epilepsy patients can agree on is that PHARMAC, the national drug-buying agency, has a tough job.
